Arsenic exposure disrupts neurite growth and complexity in vitro

NeuroToxicology

Volumn 30, Issue 4, 2009, Pages 529-537

  Frankel, Samuel ^a   Concannon, John ^a   Brusky, Kristen ^a   Pietrowicz, Erik ^a   Giorgianni, Stephen ^a   Thompson, W Douglas ^a   Currie, Douglas A ^a  

^a UNIVERSITY OF SOUTHERN MAINE   (United States)

Author keywords

Arsenic; Neurite growth; PC12

Indexed keywords

ARSENIC; ARSENITE SODIUM;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; EXPOSURE; IN VITRO STUDY; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANIMALS; ARSENATES; CELL DIFFERENTIATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL POLLUTANTS; NEURITES; NEURONS; PC12 CELLS; RATS; TIME FACTORS;

EID: 67650828540     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2009.02.015     Document Type: Article

References (88)

1. Barchowsky A., Klei L.R., Dudek E.J., Swartz H.M., and James P.E. Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite. Free Radic Biol Med 27 11-12 (1999) 1405-1412
2. Barone S., Kodavanti P.R.S., and Mundy W.R. Effects of toxicants on neural differentiation. In: Tiffany-Castiglioni E. (Ed). In vitro neurotoxicology; principles and challenges (2003), Humana Press 187-215
3. Bernstam L., and Nriagu J. Molecular aspects of arsenic stress. J Toxicol Environ Health B Crit Rev 3 4 (2000) 293-322
4. Chaineau E., Binet S., Pol D., Chatellier G., and Meininger V. Embryotoxic effects of sodium arsenite and sodium arsenate on mouse embryos in culture. Teratology 41 (1990) 105-112
5. Chattopadhyay S., Bhaumik S., Nag Chaudhury A., and Das Gupta S. Arsenic induced changes in growth development and apoptosis in neonatal and adult brain cells in vivo and in tissue culture. Toxicol Lett 128 1-3 (2002) 73-84
6. Chattopadhyay S., Bhaumik S., Purkayastha M., Basu S., Nag Chaudhuri A., and Das Gupta S. Apoptosis and necrosis in developing brain cells due to arsenic toxicity and protection with antioxidants. Toxicol Lett 136 1 (2002) 65-76
7. Chen C., Wang S., Chiou J., Tseng C., Chiou H., Hsueh Y., et al. Asenic and diabetes and hypertension in human populations: a review. Toxicol Appl Pharmacol 222 (2007) 298-304
8. Concha G., Vogler G., lezcano D., Nermell B., and Vahter M. Exposure to inorganic arsenic metabolites during early human development. Toxicol Sci 44 (1998) 185-190
9. Crumpton T., Atkins D.S., Zawia N.H., and Barone Jr. S. Lead exposure in pheochromocytoma (PC12) cells alters neural differentiation and Sp1 DNA-binding. Neurotoxicology 22 1 (2001) 49-62
10. Das K.P., Freudenrich T.M., and Mundy W.R. Assessment of PC12 differentiation and neurite growth: a comparison of morphological and neurochemical measures. Neurotoxicol Teratol 26 (2004) 397-406
11. DeFuria J., and Shea T.B. Arsenic inhibits neurofilament transport and induces perikaryal accumulation of phosphorylated neurofilaments: roles of JNK and GSK-3beta. Brain Res 1181 (2007) 74-82
12. Dichter M.A., Tischler A.S., and Greene L.A. Nerve growth factor-induced increase in electrical excitability and acetylcholine sensitivity of a rat pheochromocytoma cell line. Nature 268 (1977) 501-504
13. Dong Z. The molecular mechanisms of arsenic-induced cell transformation and apoptosis. Environ Health Perspect 110 5 (2002) 757-759
14. Eom D.S., Choi W.S., Ji S., Cho J.W., and Oh Y.J. Activation of c-Jun N-terminal kinase is required for neurite outgrowth of dopaminergic neuronal cells. Neuroreport 16 8 (2005) 823-828
15. EPA (2001). http://www.epa.gov/safewater/arsenic/regulations.html.
16. Ferreccio C., and Sancha A.M. Arsenic exposure and its impact on health in Chile. J Health Popul Nutr 24 2 (2006) 164-175
17. Fincher R.M., and Koerker R.M. Long-term survival in acute arsenic encephalopathy. Follow-up using newer measures of electrophysiologic parameters. Am J Med 82 3 (1987) 549-552
18. 3) induced calcium signals and cytotoxicity in two human cell lines: SY-5Y neuroblastoma and 293 embryonic kidney (HEK). Toxicol Appl Pharmacol 220 3 (2007) 292-301
19. Florea A.M., and Büsselberg D. Arsenic trioxide in environmentally and clinically relevant concentrations interacts with calcium homeostasis and induces cell type specific cell death in tumor and non-tumor cells. Toxicol Lett 179 1 (2008) 34-42
20. Fujita K., Lazarovici P., and Guroff G. Regulation of the differentiation of PC12 pheochromocytoma cells. Environ Health Perspect 80 (1989) 127-142
21. Geldof A.A. Nerve-growth-factor-dependent neurite outgrowth assay; a research model for chemotherapy-induced neuropathy. J Cancer Res Clin Oncol 121 (1995) 657-660
22. Goebel H.H., Schmidt P.F., Bohl J., Tettenborn B., Krämer G., and Gutmann L. Polyneuropathy due to acute arsenic intoxication: biopsy studies. J Neuropathol Exp Neurol 49 (1990) 137-149
23. Gomez T.M., and Zheng J.Q. The molecular basis for calcium-dependent axon pathfinding. Nat Rev Neurosci 7 2 (2006) 115-125
24. Grandjean P., and Landrigan P.J. Developmental neurotoxicity of industrial chemicals. Lancet 368 9553 (2006) 2167-2178
25. Greene L.A., and Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73 7 (1976) 2424-2428
26. Greene L.A., and Angelastro J.M. You can't go home again: transcriptionally driven alterations of cell signaling by NGF. Neurochem Res 30 (2005) 1347-1352
27. Haque R., Mazumder D.N., Samanta S., Ghosh N., Kalman D., Smith M.M., et al. Arsenic in drinking water and skin lesions: dose-response data from West Bengal, India. Epidemiology 14 2 (2003) 174-182
28. Hafeman D.M., Ahsan H., Louis E.D., Siddique A.B., Slavkovich V., Cheng Z., et al. Association between arsenic exposure and a measure of subclinical sensory neuropathy in Bangladesh. J Occup Environ Med 47 (2005) 778-784
29. Heidemann S.R., Joshi H.C., Schechter A., Fletcher J.R., and Bothwell M. Synergistic effects of cyclic AMP and nerve growth factor on neurite outgrowth and microtubule stability of PC12 cells. J Cell Biol 100 3 (1985) 916-927
30. Heikens A., Panaullah G.M., and Meharg A.A. Arsenic behavior from groundwater and soil to crops: impacts on agriculture and food safety. Rev Environ Contamin Toxicol 189 (2007) 43-87
31. Hoffman P.N., Griffin J.W., Gold B.G., and Price D.L. Slowing of neurofilament transport and the radial growth of developing nerve fibers. J Neurosci 5 11 (1985) 2920-2929
32. Hood R.D., Vedel G.C., Zaworotko M.J., Tatum F.M., and Meeks R.G. Uptake, distribution, and metabolism of trivalent arsenic in the pregnant mouse. J Toxicol Environ Health 25 (1988) 423-434
33. Hood R.D., and Bishop S.L. Teratogenic effects of sodium arsenate in mice. Arch Enivron Health 24 (1992) 62-65
34. Jalink K., van Corven E.J., Hengeveld T., Morii N., Narumiya S., and Moolenaar W.H. Inhibition of lysophosphatidate- and thrombin-induced neurite retraction and neuronal cell rounding by ADP ribosylation of the small GTP-binding protein. J Cell Biol 126 3 (1994) 801-810
35. Jin Y., Xi S., Li X., Lu C., Li G., Xu Y., et al. Arsenic speciation transported through the placenta from mother mice to their newborn pups. Environ Res 101 3 (2006) 349-355
36. Joshi H.C., Chu D., Buxbaum R.E., and Heidemann S.R. Tension and compression in the cytoskeleton of PC 12 neurites. J Cell Biol 101 3 (1985) 697-705
37. Kern M., and Audesirk G. Inorganic lead may inhibit neurite development in cultured rat hippocampal neurons through hyperphosphorylation. Toxicol Appl Pharmacol 134 1 (1995) 111-123
38. Kishi Y., Sasaki H., Yamasaki H., Ogawa K., Nishi M., and Nanjo K. An epidemic of arsenic neuropathy from a spiked curry. Neurology 56 (2001) 1417-1418
39. Leong C.C., Syed N.I., and Lorscheider F.L. Retrograde degeneration of neurite membrane structural integrity of nerve growth cones following in vitro exposure to mercury. Neuroreport 12 4 (2001) 733-737
40. Le Quesne P.M., and McLeod J.G. Peripheral neuropathy following a single exposure to arsenic. Clinical course in four patients with electrophysiological and histological studies. J Neurol Sci 32 3 (1977) 437-451
41. Li W., and Chou I.N. Effects of sodium arsenite on the cytoskeleton and cellular glutathione levels in cultured cells. Toxicol Appl Pharmacol 114 (1992) 132-139
42. Li Y.M., and Broome J.D. Arsenic targets tubulins to induce apoptosis in myeloid leukemia cells. Cancer Res 59 (1999) 776-780
43. Ling Y.H., Jiang J.D., Holland J.F., and Perez-Soler R. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines. Mol Pharmacol 62 (2002) 529-538
44. Liu J., Zheng B., Aposhian H.V., Zhou Y., Chen M.L., Zhang A., et al. Chronic arsenic poisoning from burning high-arsenic-containing coal in Guizhou China. Environ Health Perspect 110 2 (2002) 119-122
45. McAllister A.K. Cellular and molecular mechanisms of dendrite growth. Cereb Cortex 10 10 (2000) 963-973
46. Meberg P.J., Ono S., Minamide L.S., Takahashi M., and Bamburg J.R. Actin depolymerizing factor and cofilin phosphorylation dynamics: response to signals that regulate neurite extension. Cell Motil Cytoskeleton 39 (1998) 172-190
47. Morton W.E., and Caron G.A. Encephalopathy: an uncommon manifestation of workplace arsenic poisoning?. Am J Ind Med 15 1 (1989) 1-5
48. Nagaraja T.N., and Desiraju T. Regional alterations in the levels of brain biogenic amines, glutamate, GABA, and GAD activity due to chronic consumption of inorganic arsenic in developing and adult rats. Bull Environ Contam Toxicol 50 (1993) 100-107
49. Nagaraja T.N., and Desiraju T. Effects on operant learning and brain acetylcholine esterase activity in rats following chronic inorganic arsenic intake. Hum Exp Toxicol 13 (1994) 353-356
50. Namgung U., and Xia Z. Arsenite-induced apoptosis in cortical neurons is mediated by c-Jun N-terminal protein kinase 3 and p38 mitogen-activated protein kinase. J Neurosci 20 17 (2000) 6442-6451
51. Namgung U., and Xia Z. Arsenic induces apoptosis in rat cerebellar neurons via activation of JNK3 and p38 MAP kinases. Toxicol Appl Pharmacol 174 (2001) 130-138
52. Newey S.E., Velamoor V., Govek E., and Van Aelst L. Rho GTPases, dendritic structure and mental retardation. J Neurobiol 64 (2004) 58-74
53. Nuydens R., Dispersyn G., de Jong M., van den Kieboom G., Borgers M., and Geerts H. Aberrant tau phosphorylation and neurite retraction during NGF deprivation in PC12 cells. Biochem Biophys Res Commun 240 3 (1997) 687-691
54. Ochi T., Nakajima F., and Fukumori N. Different effects of inorganic and dimethylated arsenic compounds on cell morphology, cytoskeletal organization, and DNA synthesis in cultured Chinese hamster V79 cells. Arch Toxicol 72 (1998) 566-573
55. Otto D., Xia Y., Li Y., Wu K., He L., Telech J., et al. Neurosensory effects of chronic human exposure to arsenic associated with body burden and environmental measures. Hum Exp Toxicol 26 (2007) 169-177
56. Parran D.K., Mundy W.R., and Barone Jr. S. Effects of methylmercury and mercuric chloride on differentiation and cell viability in PC12 cells. Toxicol Sci 59 2 (2001) 278-290
57. Pysher M.D., Chen Q.M., and Vaillancourt R.R. Arsenic alters vascular smooth muscle cell focal adhesion complexes leading to activation of FAK-src mediated pathways. Toxicol Appl Pharmacol 231 2 (2008) 135-141
58. Radio N.M., and Mundy W.R. Developmental neurotoxicity testing in vitro: models for assessing chemical effects on neurite outgrowth. Neurotoxicology 29 3 (2008) 361-376
59. Ramírez P., Eastmond D.A., Laclette J.P., and Ostrosky-Wegman P. Disruption of microtubule assembly and spindle formation as a mechanism for the induction of aneuploid cells by sodium arsenite and vanadium pentoxide. Mutat Res 386 3 (1997) 291-298
60. Robles E., and Gomez T.M. Focal adhesion kinase signaling at sites of integrin-mediated adhesion controls axon pathfinding. Nat Neurosci 9 10 (2006) 1274-1283
61. Rodríguez V.M., Carrizales L., Jimenez-Capdeville M.E., Dufour L., and Giordano M. Effects of sodium arsenite exposure on behavioral parameters in the rat. Brain Res bull 55 (2001) 301-308
62. Rodríguez V.M., Carrizales L., Mendoza M.S., Fajardo O.R., and Giordano M. Effects of sodium arsenite exposure on development and behavior in the rat. Neurotoxicol Teratol 24 (2002) 743-750
63. Rodríguez V.M., Jiménez-Capdeville M.E., and Giordano M. The effects of arsenic exposure on the nervous system. Toxicol Lett 145 (2003) 1-18
64. Rodríguez V.M., Del Razo L.M., Limón-Pacheco J.H., Giordano M., Sánchez-Peña L.C., Uribe-Querol E., et al. Glutathione reductase inhibition and methylated arsenic distribution in Cd1 mice brain and liver. Toxicol Sci 84 1 (2005) 157-166
65. Sarmiere P.D., and Bamburg J.R. Regulation of the neuronal actin cytoskeleton by ADF/cofilin. J. Neurobiol 58 (2004) 103-117
66. Schoolmeester W.L., and White D.R. Arsenic poisoning. South Med J 73 (1980) 198-208
67. Shafer T.J., and Atchison W.D. Transmitter, ion channel and receptor properties of pheochromocytome (PC12) cells: a model for neurotoxicological studies. Neurotoxicology 12 (1991) 473-492
68. Sidhu J.S., Ponc R.A., Vredevoogd M.A., Yu X., Gribble E., Hong S.W., et al. Cell cycle inhibition by sodium arsenite in primary embryonic rat midbrain neuroepithelial cells. Toxicol Sci 89 (2006) 475-484
69. Smith A.H., Lingas E.O., and Rahman M. Contamination of drinking-water by arsenic: a public health emergency. Bull World Health Organ 78 (2000) 1093-1103
70. Szeberényi J. Gene activation pathways of nerve growth factor signalling. Neurobiology 4 (1996) 1-11
71. Teng K.K., and Greene L.A. Depolarization maintains neurites and priming of PC12 cells after nerve growth factor withdrawal. J Neurosci 13 7 (1993) 3124-3135
72. Tsai S.Y., Chou H.Y., The H.W., Chen C.M., and Chen C.J. The effects of chronic arsenic exposure from drinking water on the neurobehavioral development in adolescence. Neurotoxicology 24 (2003) 747-753
73. Tseng H.P., Wang Y.H., Wu M.M., The H.W., Chiou H.Y., and Chen C.J. Association between chronic exposure to arsenic and slow nerve conduction velocity among adolescents in Taiwan. J Health Popul Nutr 24 2 (2006) 182-189
74. Vahidnia A., Romijn F., Tiller M., van der Voet G.B., and de Wolff F.A. Arsenic-induced toxicity: effect on protein composition in sciatic nerve. Hum Exp Toxicol 25 11 (2006) 667-674
75. Vahidnia A., van der Straaten R.J., Romijn F., van Pelt J., van der Voet G.B., and de Wolff F.A. Arsenic metabolites affect expression of the neurofilament and tau genes: an in-vitro study into the mechanism of arsenic neurotoxicity. Toxicol In Vitro 21 6 (2007) 1104-1112
76. Waalkes M.P., Liu J., Ward J.M., and Diwan B.A. Animal models for arsenic carcinogenesis: inorganic arsenic is a transplacental carcinogen in mice. Toxicol Appl Pharmacol 198 (2004) 377-384
77. Wang C.H., Hsiao C.K., Chen C.L., Hsu L.I., Chiou H.Y., Chen S.Y., et al. A review of the epidemiologic literature on the role of environmental arsenic exposure and cardiovascular diseases. Toxicol Appl Pharmacol 222 (2007) 315-326
78. Wasserman G.A., Liu X., Parvez F., Ahsan H., Factor-Litvak P., van Geen A., et al. Water arsenic exposure and children's intellectual function in Araihazar, Bangladesh. Environ Health Perspect 112 (2004) 1329-1333
79. Wasserman G.A., Liu X., Parvez F., Ahsan H., Factor-Litvak P., Kline J., et al. Water arsenic exposure and intellectual function in 6-year-old children in Araihazar, Bangladesh. Environ Health Perspect 115 (2007) 285-289
80. Whitford K.L., Dijkhuizen P., Polleux F., and Ghosh A. Molecular control of cortical dendrite development. Annu Rev Neurosci 25 (2002) 127-149
81. Wijeweera J.B., Gandolfi A.J., Parrish A., and Lantz R.C. Sodium arsenite enhances AP-1 and NFkappaB DNA binding and induces stress protein expression in precision-cut rat lung slices. Toxicol Sci 61 2 (2001) 283-294
82. Wlodarczyk B.J., Bennett G.D., Calvin J.A., and Finnell R.H. Arsenic-induced neural tube defects in mice: alterations in cell cycle gene expression. Reprod Toxicol 10 (1996) 447-454
83. Wu M.M., Chiou H.Y., Wang T.W., Hsueh Y.M., Wang I.H., Chen C.J., et al. Association of blood arsenic levels with increased reactive oxidants and decreased antioxidant capacity in a human population of northeastern Taiwan. Environ Health Perspect 109 10 (2001) 1011-1017
84. Xiao J., and Liu Y.J. Differential roles of ERK and JNK in early and late stages of neuritogenesis: a study in a novel PC12 model system. Neurochemistry 86 6 (2003) 1516-1523
85. Yancy S.L., Shelden E.A., Gilmont R.R., and Welsh M.J. Sodium arsenite exposure alters cell migration, focal adhesion localization and decreases tyrosine phosphorylation of focal adhesion kinase in H9C2 myoblasts. Toxicol Sci 84 2 (2005) 278-286
86. Yang C., and Frenkel K.J. Arsenic-mediated cellular signal transduction, transcription factor activation, and aberrant gene expression: implications in carcinogenesis. Environ Pathol Toxicol Oncol 21 4 (2002) 331-342
87. Yuste R., and Tank D.W. Dendritic integration in mammalian neurons, a century after Cajal. Neuron 16 (1996) 701-716
88. Yuste R., Majewska A., and Cash S. From form to function: functional exploration of dendritic morphology in CA1 pyramidal neurons. Dev Neuropsychol 16 3 (1999) 315-316